Edgemont Partners Advises ActiGraph on Sale to ArchiMed
Edgemont closes transaction for the leading global remote patient monitoring clinical research technology company NEW YORK–(BUSINESS WIRE)–Edgemont Partners (“Edgemont”), a…
Pharmaceuticals, Biotechnology and Life Sciences
Edgemont closes transaction for the leading global remote patient monitoring clinical research technology company NEW YORK–(BUSINESS WIRE)–Edgemont Partners (“Edgemont”), a…
CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that its Executive Director of Global…
A UnitedHealth Group and Yale School of Medicine study clears the way for clinical trials that could improve care and…
CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house cell line development process to provide speed, stability and high…
today announced the pricing of an underwritten public offering of 17,600,000 shares of common stock at a public offering price of $76.00 per share, before underwriting discounts and commissions.
Innovative analytics-based real-world evidence solutions to help pharma & life sciences companies optimize clinical trials for commercial success LONDON–(BUSINESS WIRE)–#Analytics—Quantzig,…
Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities SACRAMENTO, Calif.–(BUSINESS WIRE)–Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals…
AUSTIN, Texas–(BUSINESS WIRE)–Altogen Labs, a GLP-compliant contract research laboratory (CRO), offers in vivo xenograft efficacy studies and pharmacology/toxicology services designed…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Boragen Inc., a world-leading boron-based discovery platform, is proud to announce a collaboration with Dole Fresh…
QINGDAO, China & VANCOUVER, British Columbia–(BUSINESS WIRE)–Qingdao Primedicine Pharmaceutical Co. Ltd., a leading biotech company in China, and Primary Peptides…